Evidence for a secondary state of the human β3-adrenoceptor

被引:25
作者
Baker, JG [1 ]
机构
[1] Univ Nottingham, Queens Med Ctr, Inst Cell Signaling, Nottingham NG7 2UH, England
关键词
D O I
10.1124/mol.105.015461
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There are three members of the beta-adrenoceptor family, all of which are primarily coupled to G(S) proteins. Recent studies using the huge range of beta-ligands now available have given remarkable new insights into their pharmacology. beta 1-adrenoceptors exist in at least two active conformations, whereas beta 2-adrenoceptors are able to induce signaling via different agonist-induced receptor conformational states, and their affinity for antagonists can be altered by highly efficacious agonists. This study therefore examined the pharmacology of the human beta 3-adrenoceptor stably expressed in Chinese hamster ovary cells. Several compounds described previously as beta-antagonists have agonist properties at the beta 3-adrenoceptor. Antagonist affinity measurements varied at the beta 3-adrenoceptor in a manner similar to those observed at human beta 1-adrenoceptors and unlike those seen at beta 2-adrenoceptors. Some ligands ( e. g., fenoterol and cimaterol) were more readily inhibited by all antagonists, whereas other ligands [ e. g., alprenolol and 1-(2-ethylphenoxy)-3-[[(1S)-1,2,3,4-tetrahydro-1-naphthalenyl] amino](2S)-2-propanol hydrochloride [SR59230A]) stimulated responses that were more resistant to antagonism. Alprenolol inhibited fenoterol-induced beta 3-adrenoceptor responses while acting as an agonist at higher concentrations. This is highly suggestive of two active conformational states of the beta 3-adrenoceptor. (S)-4-[2-Hydroxy-3-phenoxypropylaminoethoxy]-N-(2-methoxyethyl)phenoxyacetamide (ZD7114) stimulated a two-component response, of which the first component was more readily antagonized than the second. Taken together, these experiments suggest that the human beta 3-adrenoceptor exists in at least two different agonist conformations with a similar high- and low-affinity pharmacology analogous to, if not as pronounced as, the beta 1-adrenoceptor. Both conformations are present in living cells and can be distinguished by their pharmacological characteristics. In this respect, the human beta 3-adrenoceptor seems similar to the human beta 1-adrenoceptor.
引用
收藏
页码:1645 / 1655
页数:11
相关论文
共 37 条
[1]  
ARCH JR, 2001, REV ENDOCR METAB DIS, V4, P385
[2]   β3-adrenoceptor agonists:: potential, pitfalls and progress [J].
Arch, JRS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 440 (2-3) :99-107
[3]   Do low-affinity states of β-adrenoceptors have roles in physiology and medicine? [J].
Arch, JRS .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 143 (05) :517-518
[4]   SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].
ARUNLAKSHANA, O ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58
[5]   β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors [J].
Azzi, M ;
Charest, PG ;
Angers, S ;
Rousseau, G ;
Kohout, T ;
Bouvier, M ;
Piñeyro, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (20) :11406-11411
[6]   The selectivity of β-adrenoceptor antagonists at the human β1, β2 and β3 adrenoceptors [J].
Baker, JG .
BRITISH JOURNAL OF PHARMACOLOGY, 2005, 144 (03) :317-322
[7]   Agonist and inverse agonist actions of β-blockers at the human β2-adrenoceptor provide evidence for agonist-directed signaling [J].
Baker, JG ;
Hall, IP ;
Hill, SJ .
MOLECULAR PHARMACOLOGY, 2003, 64 (06) :1357-1369
[8]   Agonist actions of "β-blockers" provide evidence for two agonist activation sites or conformations of the human β1-adrenoceptor [J].
Baker, JG ;
Hall, IP ;
Hill, SJ .
MOLECULAR PHARMACOLOGY, 2003, 63 (06) :1312-1321
[9]   Temporal characteristics of cAMP response element-mediated gene transcription: requirement for sustained cAMP production [J].
Baker, JG ;
Hall, IP ;
Hill, SJ .
MOLECULAR PHARMACOLOGY, 2004, 65 (04) :986-998
[10]   Influence of agonist efficacy and receptor phosphorylation on antagonist affinity measurements: Differences between second messenger and reporter gene responses [J].
Baker, JG ;
Hall, IP ;
Hill, SJ .
MOLECULAR PHARMACOLOGY, 2003, 64 (03) :679-688